Background
Edg receptors constitute of family of 8 GPCRs (designated as Edg-1 through Edg-8) that can be further sub-classified as sphingosine 1-phosphate receptors (S-1-P) and lysophosphatidic acid (LPA) receptors. The Edg-1 receptor is an S-1-P receptor that is coupled to a variety of intracellular responses via Gi and Go. The Edg-1 receptor was initially cloned as an immediate-early gene induced during differentiation of human endothelial cells, an in vitro model of angiogenesis. It has been shown to play a critical role in regulating cellular proliferation and survival.
| General Info | |
| Synonyms | S1P1 |
|---|---|
| Product Description | Human Edg-1 (S1P1) Lysophospholipid Receptor-expressing GPCR (G protein-coupled receptor) stable, replicating cell line. |
| Target Type | GPCR |
| Product Type | Replicating Cell Line |
| Receptor | Lysophospholipid |
| Sub-Type | EDG1 (S1P1) |
| Therapeutic Area | cancer, vascular |
| Related Services | Membrane Preparation, Large-scale Cryopreservation, GPCR Screening |
| Genbank Accession Number | NM_001400 |
| Validated Assay/Platform | binding, cAMP |
| References | Lee, M-J., Brocklyn, J.R., et al. (1998) Sphingosine-1-phosphate as a ligand for the G Protein-Coupled Receptor EDG-1. Science 279: 1552-1555. Okamoto, H., Takuwa, N. et al., (1998) EDG1 is a Functional Sphingosin-1-phsophate Receptor That is |
| Host cell | CHO-K1 |
| Mycoplasma Status | Negative (MycoAlert Kit) |
| Growth media | Ham's F12, 10% FBS, 1% NEAA, 400 µg/mL G418 |
| Storage & Packaging | |
| Packaging | Cryopreserved cells, 6 million cells per vial |
| Storage Recommendation | liquid nitrogen |
| Stability | 6 passages |
| Quantity | 6 million cells |
| Representative Screening Information | |
| Cell Line | CHO-K1 stably expressing human S1P1 sphingosine-1-phosphate receptor |
| Screening Assay | cAMP assay |
| Readout | Hit Hunter cAMP kit |
| Plate Format | 384 well |
| Instrument | FlexStation-III |
| Signal Window | 15.70 |
| Z Score | 0.75 |
| DMSO Tolerance | 0.5% DMSO |
| Testing Modes | agonist, antagonist |
| Testing Options | 16-point minimum, 4-point DRC (n = 4), 8-point DRC (n=3 or 4) |
| Turnaround Time | 2 weeks following receipt of Test Articles |
| Product Documentation | |
| Specification Sheet | |
| Screening Info | |



